Cancer: Medical Treatments
Commons · Question 93368 · Tabled 21 Nov 2025 · Department of Health and Social Care · Official record
Answered 2 Dec 2025
Question
Asked by Steve Barclay
To ask the Secretary of State for Health and Social Care, what is being done to improve the regulatory approval process for personalised medicines to treat cancer.
Answer
Answered by Zubir Ahmed, 2 Dec 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has completed a public consultation on its draft guideline on individualised mRNA cancer immunotherapies, a new type of personalised cancer treatment. These technologies use cutting-edge scien...